Radius Health Inc (RDUS)

34.56
0.57 1.68
NASDAQ : Health Care
Prev Close 33.99
Open 33.84
Day Low/High 33.74 / 34.71
52 Wk Low/High 24.75 / 79.90
Volume 692.76K
Avg Volume 972.10K
Exchange NASDAQ
Shares Outstanding 43.50M
Market Cap 1.47B
EPS -4.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm

Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm

NeuroDerm, Novavax and Nektar Therapeutics were among the biotech stock movers in premarket trading on July 24.

Radius Health Appoints Jesper Hoiland As President And Chief Executive Officer To Lead The Next Stage Of Growth And Value Creation As A Fully Integrated Commercial Biotech Company

Radius Health Appoints Jesper Hoiland As President And Chief Executive Officer To Lead The Next Stage Of Growth And Value Creation As A Fully Integrated Commercial Biotech Company

Mr. Hoiland brings unique experience in launching new products, creating growth strategies and leading high-performing organizations

Biotech Movers: BioCryst, Omeros, Radius Health

Biotech Movers: BioCryst, Omeros, Radius Health

BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.

First Week of RDUS August 18th Options Trading

Investors in Radius Health Inc saw new options become available this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new August 18th contracts and identified one put and one call contract of particular interest.

Insiders Love Bioverativ, Juno Therapeutics and More

Insiders Love Bioverativ, Juno Therapeutics and More

Insiders at Bioverativ, Juno Therapeutics and three other companies have been buying up shares of their own stock recently.

One of the World's Largest Private Equity Firms Has Seen Its Stock Soar - Now What?

One of the World's Largest Private Equity Firms Has Seen Its Stock Soar - Now What?

Here's a technical look at how to play six stocks trending higher with unusual volume flows.

First Week of RDUS January 2018 Options Trading

Investors in Radius Health Inc saw new options become available this week, for the January 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Jim Cramer: Radius Health Is a Takeover Target

Jim Cramer: Radius Health Is a Takeover Target

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Radius Health is a takeover target.

Amgen Osteoporosis Drug Approval Plan Derailed Over Heart Safety Risk -- Jim Cramer Weighs In

Amgen Osteoporosis Drug Approval Plan Derailed Over Heart Safety Risk -- Jim Cramer Weighs In

Amgen's osteoporosis setback will likely be seen as providing a commercial boost to Radius Health, which secured U.S. approval in April for a competing osteoporosis drug, Tymlos.

Biotech Movers: Radius Health, Amgen, Paratek

Biotech Movers: Radius Health, Amgen, Paratek

Radius Health, Amgen and Paratek Pharmaceuticals were among the biotech movers in premarket trading on Monday.

Six Flags, Cara Therapeutics, Hertz Global Holdings: 'Mad Money' Lightning Round

Six Flags, Cara Therapeutics, Hertz Global Holdings: 'Mad Money' Lightning Round

Jim Cramer is bullish on Six Flags and Cara Therapeutics, but he's bearish on General Motors and Pandora.

Ignore That Man in the White House? Cramer's 'Mad Money' Recap (Wednesday 5/10/17)

Ignore That Man in the White House? Cramer's 'Mad Money' Recap (Wednesday 5/10/17)

Jim Cramer says he's amazed that stocks -- and gold, even -- are just yawning at Trump's move to fire FBI Director Comey.

Insiders Are Loading Up on Twitter, Biogen & More

Insiders Are Loading Up on Twitter, Biogen & More

Insiders at Twitter, Biogen and three other companies have been snapping up shares of their own stock lately.